Little is known about the impacts of therapy on adolescent patients with T2DM. In a recent study, adolescents with newly diagnosed T2DM had profound impairment of beta-cell function, but treatment ...
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired ...
Traditionally viewed as a primarily Western disease, diabetes is becoming a global threat. While dramatic improvements in emerging economies such as China and India are facilitating middle-class ...
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired ...
A new study published in the journal of Medicine showed that both linagliptin and dapagliflozin have good safety profiles and ...
GSBR-1290 was generally well-tolerated with no treatment-related serious adverse events over 12 weeks; 2.8% study discontinuation rate due to adverse events related to study drug in diabetes and 0% ...
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong ...
Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...
The diagram illustrates the RNAkine-mediated glucose metabolic regulatory network involving various secreted organs, including pancreas, adipose tissue, skeletal muscle, and liver, which have critical ...
Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results